Compare TTK HEALTHCARE with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DISHMAN PHARMA TTK HEALTHCARE/
DISHMAN PHARMA
 
P/E (TTM) x 18.8 25.1 74.7% View Chart
P/BV x 1.5 3.3 44.9% View Chart
Dividend Yield % 1.0 0.7 154.9%  

Financials

 TTK HEALTHCARE   DISHMAN PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
DISHMAN PHARMA
Mar-16
TTK HEALTHCARE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,215374 324.5%   
Low Rs610129 473.3%   
Sales per share (Unadj.) Rs444.4197.8 224.7%  
Earnings per share (Unadj.) Rs17.221.2 81.3%  
Cash flow per share (Unadj.) Rs27.634.7 79.6%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.50.8 68.9%  
Book value per share (Unadj.) Rs177.9179.9 98.9%  
Shares outstanding (eoy) m14.1380.69 17.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.11.3 161.4%   
Avg P/E ratio x52.911.9 445.9%  
P/CF ratio (eoy) x33.07.2 455.7%  
Price / Book Value ratio x5.11.4 366.6%  
Dividend payout %29.09.4 307.4%   
Avg Mkt Cap Rs m12,89420,306 63.5%   
No. of employees `0002.30.8 278.9%   
Total wages/salary Rs m1,3075,355 24.4%   
Avg. sales/employee Rs Th2,715.719,252.7 14.1%   
Avg. wages/employee Rs Th565.36,459.5 8.8%   
Avg. net profit/employee Rs Th105.42,064.1 5.1%   
INCOME DATA
Net Sales Rs m6,27915,961 39.3%  
Other income Rs m78265 29.2%   
Total revenues Rs m6,35616,226 39.2%   
Gross profit Rs m4964,103 12.1%  
Depreciation Rs m1471,091 13.5%   
Interest Rs m34944 3.6%   
Profit before tax Rs m3932,334 16.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m149624 23.9%   
Profit after tax Rs m2441,711 14.2%  
Gross profit margin %7.925.7 30.7%  
Effective tax rate %37.926.7 141.9%   
Net profit margin %3.910.7 36.2%  
BALANCE SHEET DATA
Current assets Rs m2,71711,018 24.7%   
Current liabilities Rs m1,5719,517 16.5%   
Net working cap to sales %18.39.4 194.2%  
Current ratio x1.71.2 149.4%  
Inventory Days Days32110 29.1%  
Debtors Days Days4735 133.9%  
Net fixed assets Rs m99116,304 6.1%   
Share capital Rs m141161 87.5%   
"Free" reserves Rs m2,37312,907 18.4%   
Net worth Rs m2,51414,516 17.3%   
Long term debt Rs m34,189 0.1%   
Total assets Rs m4,15829,805 14.0%  
Interest coverage x12.63.5 363.5%   
Debt to equity ratio x00.3 0.5%  
Sales to assets ratio x1.50.5 282.0%   
Return on assets %6.78.9 74.9%  
Return on equity %9.711.8 82.2%  
Return on capital %16.917.5 96.6%  
Exports to sales %3.624.8 14.5%   
Imports to sales %0.53.7 13.2%   
Exports (fob) Rs m2253,956 5.7%   
Imports (cif) Rs m31596 5.2%   
Fx inflow Rs m2254,952 4.5%   
Fx outflow Rs m71697 10.2%   
Net fx Rs m1544,255 3.6%   
CASH FLOW
From Operations Rs m1732,786 6.2%  
From Investments Rs m97-1,529 -6.3%  
From Financial Activity Rs m-307-941 32.7%  
Net Cashflow Rs m-38316 -11.9%  

Share Holding

Indian Promoters % 65.4 61.4 106.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 3.7 100.0%  
FIIs % 5.2 12.7 40.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 22.1 116.7%  
Shareholders   12,723 46,261 27.5%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PROCTER & GAMBLE HEALTH  CIPLA  TORRENT PHARMA  SUVEN LIFESCIENCES  WYETH LTD  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Jumps 1,921 Points, FM's Tax Relief, and Top Cues in Focus Today(Pre-Open)

Share markets in India jumped sharply on Friday after Finance Minister Nirmala Sitharaman announced a slew of measures in her media briefing ahead of the GST Council meet.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 20, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - UNICHEM LAB COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS